Search

everythinglearnresearchcommunity

for

Search:↓

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Including androgens in hormone therapy may lower breast cancer risk.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Both estrogens and androgens are important for health in both males and females.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.